يعرض 1 - 10 نتائج من 1,690 نتيجة بحث عن '"F. Smit"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Investigating non-inferiority of internet-delivered versus face-to-face cognitive behavioural therapy for insomnia (CBT-I): a randomised controlled trial (iSleep well)

    المؤلفون: F. Benz, L. Grolig, S. Hannibal, C. Buntrock, P. Cuijpers, K. Domschke, D. D. Ebert, J. Ell, M. Janneck, C. Jenkner, A. F. Johann, A. Josef, M. Kaufmann, A. Koß, T. Mallwitz, H. Mergan, C. M. Morin, D. Riemann, H. Riper, S. R. Schmid, F. Smit, L. Spille, L. Steinmetz, E. J. W. Van Someren, K. Spiegelhalder, D. Lehr

    المصدر: Trials, Vol 25, Iss 1, Pp 1-17 (2024)

    مصطلحات موضوعية: Insomnia, CBT-I, Cognitive behavioural therapy for insomnia, Internet-delivered, Digital, Face-to-face, Medicine (General), R5-920

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/1745-6215

    URL الوصول: https://doaj.org/article/13736233927b4f3d98ad1be2091300e9

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer.

    المؤلفون: Karlijn Hummelink, Vincent van der Noort, Mirte Muller, Robert D Schouten, Michel M van den Heuvel, Daniela S Thommen, Egbert F Smit, Gerrit A Meijer, Kim Monkhorst

    المصدر: PLoS ONE, Vol 19, Iss 7, p e0293707 (2024)

    مصطلحات موضوعية: Medicine, Science

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/1932-6203

    URL الوصول: https://doaj.org/article/6b18e0bcb87f45658fff43824048aa27

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  3. 3
    Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC

    المؤلفون: Sophie M. Ernst, Joanne M. Mankor, Job van Riet, Jan H. von der Thüsen, Hendrikus J. Dubbink, Joachim G.J.V. Aerts, Adrianus J. de Langen, Egbert F. Smit, Anne-Marie C. Dingemans, Kim Monkhorst

    المساهمون: Pulmonary Medicine, Medical Oncology, Pathology

    المصدر: Journal of Thoracic Oncology, 18(4), 487-498. International Association for the Study of Lung Cancer

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, SDG 3 - Good Health and Well-being

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00cf9743a1479a3c4eba3c64ec721d08
    http://www.scopus.com/inward/record.url?scp=85146015148&partnerID=8YFLogxK

    أضف إلى المفضلة
  4. 4
    Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

    المؤلفون: Tomohide Tamura, Kazumasa Noda, Shinzoh Kudoh, José Baselga, Johan Vansteenkiste, Giuseppe Giaccone, Seiji Yano, Takeshi Horai, Kazuhiko Nakagawa, Ichiro Takata, Rui Ping Dong, Masahiro Fukuoka, Egbert F. Smit, Jean-Yves Douillard, Danny Rischin, Richard Eek, A. Feyereislova, Steven D. Averbuch, Yutaka Nishiwaki, Angela Macleod

    المصدر: Journal of Clinical Oncology. 41:1162-1171

    مصطلحات موضوعية: medicine.medical_specialty, Chemotherapy, Cancer Research, Randomization, business.industry, medicine.medical_treatment, medicine.disease, Gastroenterology, Surgery, law.invention, Clinical trial, Gefitinib, Randomized controlled trial, Tolerability, Oncology, law, Internal medicine, medicine, business, Lung cancer, Survival rate, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ccc160e40821bcd68e21184b9491e2
    https://doi.org/10.1200/jco.22.02499

    أضف إلى المفضلة
  5. 5
    Pharmacokinetic boosting of osimertinib with cobicistat in patients with non-small cell lung cancer

    المؤلفون: Ard van Veelen, Judith Gulikers, Lizza E.L. Hendriks, Safiye Dursun, Juanita Ippel, Egbert F. Smit, Anne-Marie C. Dingemans, Robin van Geel, Sander Croes

    المساهمون: MUMC+: DA KFT Medische Staf (9), RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, Clinical Pharmacy, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), Pulmonary Medicine, CCA - Cancer Treatment and quality of life

    المصدر: van Veelen, A, Gulikers, J, Hendriks, L E L, Dursun, S, Ippel, J, Smit, E F, Dingemans, A-M C, van Geel, R & Croes, S 2022, ' Pharmacokinetic boosting of osimertinib with cobicistat in patients with non-small cell lung cancer : The OSIBOOST trial ', Lung Cancer, vol. 171, pp. 97-102 . https://doi.org/10.1016/j.lungcan.2022.07.012
    Lung Cancer, 171, 97-102. Elsevier Ireland Ltd

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Cancer Research, TENOFOVIR DISOPROXIL FUMARATE, CYP3A4, Indoles, Lung Neoplasms, HIV-1 INFECTION, PHASE-3, RITONAVIR, Antineoplastic Agents, NSCLC, Proof of Concept Study, DOUBLE-BLIND, SDG 3 - Good Health and Well-being, Carcinoma, Non-Small-Cell Lung, Humans, EXPOSURE, Protein Kinase Inhibitors, ELVITEGRAVIR, Acrylamides, Aniline Compounds, INHIBITOR, ErbB Receptors, Pharmacokinetic boosting, Pyrimidines, Oncology, INITIAL TREATMENT, Mutation, EMTRICITABINE, Cobicistat, Osimertinib

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e90c1d695c2e87afae94bff515d7d9b5
    http://www.scopus.com/inward/record.url?scp=85135538552&partnerID=8YFLogxK

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  6. 6
    Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer

    المؤلفون: G.D. Marijn Veerman, Rene J. Boosman, Merel Jebbink, Esther Oomen-de Hoop, Anthonie J. van der Wekken, Idris Bahce, Lizza E.L. Hendriks, Sander Croes, Christi M.J. Steendam, Evert de Jonge, Stijn L.W. Koolen, Neeltje Steeghs, Ron H.N. van Schaik, Egbert F. Smit, Anne-Marie C. Dingemans, Alwin D.R. Huitema, Ron H.J. Mathijssen

    المساهمون: Pulmonary medicine, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, Medical Oncology, Pulmonary Medicine, Clinical Chemistry, Pharmacy

    المصدر: EClinicalMedicine, 59:101955. Lancet Publishing Group
    EClinicalMedicine, 59:101955. Elsevier
    Veerman, G D M, Boosman, R J, Jebbink, M, Oomen-de Hoop, E, van der Wekken, A J, Bahce, I, Hendriks, L E L, Croes, S, Steendam, C M J, de Jonge, E, Koolen, S L W, Steeghs, N, van Schaik, R H N, Smit, E F, Dingemans, A-M C, Huitema, A D R & Mathijssen, R H J 2023, ' Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer ', EClinicalMedicine, vol. 59, 101955 . https://doi.org/10.1016/j.eclinm.2023.101955

    مصطلحات موضوعية: Single-nucleotide polymorphism, Non-small cell lung cancer, SDG 3 - Good Health and Well-being, Drug transporters, Brain metastases, Pharmacokinetics, General Medicine, Osimertinib

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d9a0a2bc22225c345fc12f4aef0a124
    https://doi.org/10.1016/j.eclinm.2023.101955

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  7. 7
    Supplementary Table S2 from Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor–Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations

    المؤلفون: William Pao, Vincent A. Miller, Vikram K. Chand, Yali Fu, Bushi Wang, Gregory J. Riely, D. Ross Camidge, Scott Gettinger, Leora Horn, Harry J.M. Groen, Egbert F. Smit, Yelena Y. Janjigian

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc2f2bb3f801ec0d538a11c2271ee8d4
    https://doi.org/10.1158/2159-8290.22532278

    أضف إلى المفضلة
  8. 8
    Supplementary Table S4 from Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer

    المؤلفون: Julian Downward, Katerina Politi, Egbert F. Smit, René Bernards, Harold Varmus, Marc Ladanyi, Yixuan Gong, Almudena García-Castaño, Javier Gómez-Román, Daniëlle A.M. Heideman, Guus J. Heynen, Anna Wurtz, Zenta Walther, Scott Gettinger, Mary Ann Melnick, Rebecca E. Saunders, Ming Jiang, Patricia H. Warne, Catherine Cowell, Elza C. de Bruin

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17fc1bd0ab84567b3626be4fede6e78f
    https://doi.org/10.1158/2159-8290.22529726

    أضف إلى المفضلة
  9. 9
    Supplementary Tables S1 and S2 from Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer

    المؤلفون: Julian Downward, Katerina Politi, Egbert F. Smit, René Bernards, Harold Varmus, Marc Ladanyi, Yixuan Gong, Almudena García-Castaño, Javier Gómez-Román, Daniëlle A.M. Heideman, Guus J. Heynen, Anna Wurtz, Zenta Walther, Scott Gettinger, Mary Ann Melnick, Rebecca E. Saunders, Ming Jiang, Patricia H. Warne, Catherine Cowell, Elza C. de Bruin

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1308461c69c1695477cd20778f15b489
    https://doi.org/10.1158/2159-8290.22529723.v1

    أضف إلى المفضلة
  10. 10
    Supplementary Figures 1-7 from Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer

    المؤلفون: Julian Downward, Katerina Politi, Egbert F. Smit, René Bernards, Harold Varmus, Marc Ladanyi, Yixuan Gong, Almudena García-Castaño, Javier Gómez-Román, Daniëlle A.M. Heideman, Guus J. Heynen, Anna Wurtz, Zenta Walther, Scott Gettinger, Mary Ann Melnick, Rebecca E. Saunders, Ming Jiang, Patricia H. Warne, Catherine Cowell, Elza C. de Bruin

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec3ff2c4a77fe7096343582e01b356b
    https://doi.org/10.1158/2159-8290.22529732.v1

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء